MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PRQR — ProQR Therapeutics N.V. Ordinary Shares
NasdaqProQR Therapeutics N.V. Ordinary Shares
$1.63
-0.02(-1.21%)
- O
- 1.63
- H
- 1.64
- L
- 1.60
- V
- 406K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PRQR
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
IndustryCommon Stock
SectorNot available
IPO DateSep 18, 2014
Employees187
Stock ExchangeNasdaq
Ticker SymbolPRQR
Websitehttps://www.proqr.com
Key Financial Statistics
| Market Cap | $230.73M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.33 - $3.10 |
| 52-Week Avg Volume | 690.9K |
| VWAP | $1.62 |
| Transactions | 1,979 |
| Total Recorded Bars | 3,031 days |